共 50 条
Prostate cancer stem cells: an updated mini-review
被引:0
|作者:
Zhou, Kaichen
[1
]
Lu, Haosen
[1
]
Zhang, Jielin
[2
]
Shen, Qi
[2
]
Liu, Pengzhan
[2
]
Xu, Qiqing
[2
]
Yang, Chunhua
[2
]
Mao, Lijun
[1
,2
]
机构:
[1] Xuzhou Med Univ, Dept Urol, Affiliated Hosp, Xuzhou 221000, Peoples R China
[2] Xuzhou Med Univ, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R China
来源:
JOURNAL OF CANCER
|
2024年
/
15卷
/
20期
关键词:
Stem cells;
prostate cancer stem cells;
surface markers;
signaling pathway;
therapy;
INITIATING CELLS;
SIDE POPULATION;
IDENTIFICATION;
MARKERS;
BASAL;
CD44;
SUBPOPULATION;
INHIBITION;
EXPRESSION;
ANDROGEN;
D O I:
10.7150/jca.100604
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Prostate cancer is the most common malignant tumor in male genitourinary system. The incidence of prostate cancer ranks the first among all male malignant tumors worldwide, and the mortality rate ranks the second among all male malignant tumors. Prostate stem cells are heterogeneous subsets with the function of self-regeneration and proliferation in the prostate, which can produce all cell lineages that make up the prostate epithelium. At present, the pathogenesis of prostate cancer remains unclear. According to cancer stem cell hypothesis, prostate cancer may be a stem cell disease, which provides a new direction for revealing the pathogenesis of prostate cancer and developing treatment strategy for prostate cancer. In this mini-review, we highlight recent advances in our understanding of the origin, surface molecular markers, signaling pathway and the significance for clinical treatment of prostate cancer stem cells.
引用
收藏
页码:6570 / 6576
页数:7
相关论文